Key Cellular Enzyme found that could be Effective Drug Target for Urologic Cancer Cells
Researchers at the SUNY Upstate Medical University have found that a key cellular enzyme, c-Abl, could be an effective drug target in cancer cells for urologic cancers, such as prostate and kidney. Currently kidney cancer is known to be resistant against chemotherapy and radiation. About 61,000 new cases of kidney cancer are diagnosed each year,